Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis

NCT00440986 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2007-03-01

No results posted yet for this study

Summary

The purpose of study is to determine the best and durable choice of treatment between phlebotomy and eritrocytoapheresis in the medium- and long-term clinical management of HH

Conditions

  • Hereditary Hemochromatosis

Interventions

PROCEDURE

Eritrocytoapheresis

Sponsors & Collaborators

  • San Filippo Neri General Hospital

    lead OTHER

Principal Investigators

  • Francesco Equitani, M.D. · San Filippo Neri General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-04-30
Completion
2006-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00440986 on ClinicalTrials.gov